Chest Pain News and Research

RSS

Two established atrial fibrillation ablation techniques show similar effects, safety outcomes

Two established techniques for correcting the root cause of the heart rhythm disorder atrial fibrillation show similar effects and safety outcomes, according to research presented at the American College of Cardiology's 65th Annual Scientific Session.

5 Apr 2016

Tests used for diagnosing heart disease appear to function differently for women and men

Tests used to diagnose and assess the severity of coronary artery disease appear to function differently for women and men who have stable symptoms, according to researchers from Duke Clinical Research Institute.

5 Apr 2016

Patient-oriented tool helps shared decision-making between patients and physicians for chest pain

Patients who arrive at the emergency department with low-risk chest pain and talk through treatment options with a physician show improved knowledge of their health status and follow-up options, compared with patients who received standard counseling from a physician, according to Mayo Clinic research presented at the American College of Cardiology's 65th Annual Scientific Session.

4 Apr 2016

Heart disease patients who experience mental stress ischemia tend to have higher levels of troponin

Some people with heart disease experience a restriction of blood flow to the heart in response to psychological stress. Usually silent (not painful), the temporary restriction in blood flow, called ischemia, is an indicator of greater mortality risk.

4 Apr 2016

Cholesterol drug evacetrapib fails to reduce risk of cardiovascular events

Despite lowering low-density lipoprotein (LDL), known as "bad" cholesterol, while markedly increasing levels of high-density lipoprotein (HDL), or "good" cholesterol, a large clinical trial to investigate the cholesterol drug evacetrapib was discontinued early after a preliminary analysis showed it did not reduce rates of major adverse cardiovascular events, according to research presented at the American College of Cardiology's 65th Annual Scientific Session.

4 Apr 2016

Loyola to conduct clinical trial of new procedure to treat atrial fibrillation

Loyola Medicine is enrolling patients in a landmark clinical trial of a new procedure to treat atrial fibrillation, the most common type of irregular heartbeat.

2 Apr 2016

Research shows women have more risk factors for heart disease

Despite messages to the contrary, most women being seen by a doctor for the first time with suspected heart disease actually experience the same classic symptoms as men, notably chest pain and shortness of breath, according to a study led by the Duke Clinical Research Institute.

24 Mar 2016

Stress management can cut risk of another heart attack by half

Patients recovering from heart attacks or other heart trouble could cut their risk of another heart incident by half if they incorporate stress management into their treatment, according to research from Duke Health.

22 Mar 2016

Orexigen Therapeutics, Valeant Pharmaceuticals sign distribution agreement for Mysimba

Orexigen Therapeutics, Inc. today announced Valeant Pharmaceuticals International, Inc. will commercialize Mysimba (naltrexone HCl / bupropion HCl prolonged release) in Central and Eastern Europe.

15 Mar 2016

Paroxysmal AF patients who practice yoga have better quality of life

Yoga improves quality of life in patients with paroxysmal atrial fibrillation, according to research published today in the European Journal of Cardiovascular Nursing. Heart rate and blood pressure also decreased in patients who did yoga.

14 Mar 2016

Bariatric surgery reduces incidence of heart failure exacerbation in patients with morbid obesity

A new study led by Massachusetts General Hospital investigators finds that heart failure patients who underwent bariatric surgery to treat morbid obesity had a significant reduction in the incidence of heart failure exacerbation - a dangerous, sudden worsening of symptoms - in the two years following surgery.

27 Feb 2016

Novartis announces FDA approval of Afinitor for progressive, nonfunctional neuroendocrine tumors of GI

Novartis today announced that the United States Food and Drug Administration approved Afinitor (everolimus) tablets for the treatment of adult patients with progressive, well-differentiated, nonfunctional neuroendocrine tumors (NET) of gastrointestinal (GI) or lung origin that are unresectable, locally advanced or metastatic.

26 Feb 2016

Allergan's sNDA for TEFLARO (ceftaroline fosamil) accepted by FDA

Allergan plc today announced the U.S. Food and Drug Administration has accepted for filing the company's supplemental New Drug Application (sNDA) for TEFLARO (ceftaroline fosamil).

16 Feb 2016

Atypical heart attack symptoms lead to delayed treatment, increased injury in women

When having a heart attack, most people will experience some kind of chest pain or pressure that worsens. Pain and pressure, along with sweating, shortness of breath and pain that migrates into the arms or neck are the typical heart attack symptoms.

12 Feb 2016

Bradycardia does not increase cardiovascular disease risk

Bradycardia - a slower than normal heartbeat - does not increase the risk of developing cardiovascular disease, according to a study conducted by researchers at Wake Forest Baptist Medical Center. The study is published in the Jan.19 online edition of the Journal of American Medical Association Internal Medicine.

19 Jan 2016

Troponin T test provides possible one hour diagnosis of heart attack

Results from the TRAPID-AMI clinical study have been published online by the Annals of Emergency Medicine, confirming a novel approach for a more rapid diagnosis of heart attack in patients with acute chest pain.

From Roche Sequencing and Life Science 15 Jan 2016

New doctoral thesis reveals potential treatment for stress-induced cardiomyopathy

Stress induced cardiomyopathy after cerebral hemorrhage has been shown to increase the risk of further brain damage. These patients can now be identified by a simple blood test, and a possible treatment for stress induced cardiomyopathy has been discovered - a different kind of anesthesia than that currently being used. A new doctoral thesis at Sahlgrenska Academy has explored these issues.

26 Nov 2015

Angina in women linked with abnormal heart blood flow

Chest pain in female-pattern heart disease is linked with abnormal heart blood flow, demonstrated with a drug commonly used to alleviate chest pain patients with coronary artery disease, which was found to be ineffective in patients with moderate female-pattern heart disease, but may offer some relief for sicker patients, a new Cedars-Sinai Heart Institute study shows.

12 Nov 2015

Noninvasive CT scans far better than stress tests at spotting clogged arteries

Results of a head-to-head comparison study led by Johns Hopkins researchers show that noninvasive CT scans of the heart's vessels are far better at spotting clogged arteries that can trigger a heart attack than the commonly prescribed exercise stress that most patients with chest pain undergo.

27 Oct 2015

St. Luke's Community Education Center dedicated at Cetronia Ambulance Corps

Today, the new St. Luke’s Community Education Center at Cetronia Ambulance Corps was unveiled in a dedication ceremony with administrators, first responders and physicians.

22 Oct 2015

Chest Pain News and Research

Two established atrial fibrillation ablation techniques show similar effects, safety outcomes

Tests used for diagnosing heart disease appear to function differently for women and men

Patient-oriented tool helps shared decision-making between patients and physicians for chest pain

Heart disease patients who experience mental stress ischemia tend to have higher levels of troponin

Cholesterol drug evacetrapib fails to reduce risk of cardiovascular events

Loyola to conduct clinical trial of new procedure to treat atrial fibrillation

Research shows women have more risk factors for heart disease

Stress management can cut risk of another heart attack by half

Orexigen Therapeutics, Valeant Pharmaceuticals sign distribution agreement for Mysimba

Paroxysmal AF patients who practice yoga have better quality of life

Bariatric surgery reduces incidence of heart failure exacerbation in patients with morbid obesity

Novartis announces FDA approval of Afinitor for progressive, nonfunctional neuroendocrine tumors of GI

Allergan's sNDA for TEFLARO (ceftaroline fosamil) accepted by FDA

Atypical heart attack symptoms lead to delayed treatment, increased injury in women

Bradycardia does not increase cardiovascular disease risk

Troponin T test provides possible one hour diagnosis of heart attack

New doctoral thesis reveals potential treatment for stress-induced cardiomyopathy

Angina in women linked with abnormal heart blood flow

Noninvasive CT scans far better than stress tests at spotting clogged arteries

St. Luke's Community Education Center dedicated at Cetronia Ambulance Corps

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News